Methylphenidate, Rivastigmine or Haloperidol in Hypoactive Delirium in Intensive Care Patients
Status:
Terminated
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this pilot-trial is the feasibility of a large randomized, placebo controlled,
doubleblind clinical trial to investigate the use of methylphenidate, rivastigmine or
haloperidol in hypoactive ICU-delirium. In addition we will compare duration of delirium,
severity of delirium, length of ICU/hospital stay and side effects between the different
interventions.